BIBLIOGRAFÍA 1. Selly S., Donovan J. Diagnosis, management and screening of early localized prostate cancer; Health Technology Assessment 1997; Vol. 1: No. 2 (Executive summary) 2. Sitas F, Madhoo J, Wessie J. National Cancer Registry of South Africa. Incidence of histoligically diagnosed cancer in South Africa, 1993-1995. Johannesburg: South African Institute for Medical Research, 1998 3. Boring CC, Squires TS. Cancer Statistics 1992. CA 1992; 42:19. 4. Silverberg E. Statistical and epidemiological data on urologic cancer. Cancer 1987; 60:692. 5. Underwood W, Rubin MA, Montie JE, Manley S, Sanda MG. Prostate cancers among African Americans are similarly responsive to radical prostatectomy as are Caucasian prostate cancers of matched stage and grade. Program and abstracts of the American Urological Association 96th Annual Meeting; June 2-7, 2001; Anaheim, California. Abstract 265. 6. Paquette EL, Connelly RR, Sun L, et al. Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the PSA-era: implications for screening a high risk group for prostate cancer. Program and abstracts of the 96th Annual Meeting of the American Urological Association; June 2-7, 2001; Anaheim, California. Abstract 266. 7. Catalona WJ, Roehl KA, Antenor J. Screening for prostate cancer in high-risk populations. Program and abstracts of the 96th Annual Meeting of the American Urological Association; June 2-7, 2001; Anaheim, California. Abstract 257. 8. Sitas F. Histologically diagnosed cancers in South Africa. S Afr. Med J. 1994; 84:344. 9. Somdyala N, Marasas W. Cancer patterns in four districts of the Transkei region 1991-1995. S Afr Med J. 2003:93(2) 144-148 10. Makaula N, Marasas WFO. Oesophageal and other cancer patterns in four selected districts of Transkei, Soutern Africa: 1985-1990. Afr J Med J Sci 1996;3: 11-15 11. Sitas F, Madhoo J, Wessie J. Incidence of Histollogicaly Diagnosed Cancer in South Africa, 1993-1995. National Cancer Registry of South Africa, South African Institute for Medical Research, Johannesburg, 1998 12. Sommer F, Klotz T Lifestyle issues and genitourinary tumours World J Urol. 2003 12: 26-29 13. Stopforth HB, Heyns CF, Allen FJ. Prostate cancer in the Western Cape province, South Africa. African Journal of Urology 1998; 4(2): 56-60 14. Gueye SM, Zeigler-JohnsonCM. Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men Urology 2003 ; 61(2): 987-992 15. Vogelzang N, Localized Prostate Cancer: What Are the Prognostic Criteria and the Best Approaches to Therapy? American Society of Clinical Oncology 35th Annual Meeting 1999 16. Nauman CJ, Hankins M, Siroky M, et al: Long term surveillance of men with high grade prostatic intraepithelial neoplasia (P.I.N.) [Abstract 1191]. American Society of Clinical Oncology, 35th Annual Meeting, Atlanta, 1999. 17. D'Amico AV, Whittington R, Malkowicz SB: PSA outcome after radical prostatectomy for patients with clinically localized prostate cancer: the clinical utility of the percent positive biopsies [Abstract 1192]. American Society of Clinical Oncology, 35th Annual Meeting, Atlanta, 1999 18. Sandler HM, Pajak TF, Hanks GE, et al. Can biochemical failure (ASTRO definition) be used as a surrogate end point for prostate cancer survival in phase III localized prostate cancer clinical trials? Analysis of RTOG protocol 92-02. Program and abstracts of the 39th Annual Meeting of the American Society of Clinical Oncology; May 31-June 3, 2003; Chicago, Illinois. Abstract 1529.
|